Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Sushil Suri
FOLLOW
Sushil suri, Latest News
Business :
Morepen approves Rs 433 crore investment from Swiss-based Corinth
Morepen Laboratories said on Friday it has approved an incoming investment of Rs 433 crore to Corinth Investment Holdings AG of Switzerland. ...
Business :
Morepen Labs clocks Q1 net profit at Rs 19 cr, announces Rs 178 cr expansion plan
Morepen Laboratories on Monday reported a sharp upsurge of 153 per cent in its consolidated net profit at Rs 19.37 crore in the quarter ended June as net revenue rose by 27 per cent at Rs 259 crore. ...
National :
Use hand sanitiser only when there is no availability of soap, expert recommends
While COVID-19 pandemic has hit hard on human lives, people from every stratum of the society are keeping themselves aware and updated with the information available on public domain--- by maintaining distance, wearing a mask and carrying a bottle of ...
Business :
Morepen Laboratories gets ISO-13485 certification for its medical devices manufacturing facility at Baddi (HP)
Morepen Laboratories Ltd has received the prestigious ISO-13485 certification from BSI (British Standards Institution, UK) for its state-of-the-art medical devices manufacturing facility at Baddi (Himachal Pradesh).The certification has been awarded ...
Business :
Morepen Labs takes up the COVID battle with its infrared thermometers, hand sanitizers and face masks in Indian market
Morepen Laboratories Ltd is all set to be a frontrunner in India's fight against novel coronavirus disease, known as COVID-19. ...